Standout Papers

Cabozantinib in Progressive Medullary Thyroid Cancer 2013 2026 2017 2021 827
  1. Cabozantinib in Progressive Medullary Thyroid Cancer (2013)
    Rossella Elisei, Martin Schlumberger et al. Journal of Clinical Oncology

Immediate Impact

7 from Science/Nature 63 standout
Sub-graph 1 of 19

Citing Papers

A systems view of the vascular endothelium in health and disease
2024 Standout
Thyroid Cancer
2024 Standout
12 intermediate papers

Works of Haythem Ali being referenced

Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma
2017
Cabozantinib in Progressive Medullary Thyroid Cancer
2013 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Haythem Ali 752 486 299 610 51 1.7k
Begoña de las Heras 596 312 141 964 27 1.7k
Kamal K. Khurana 492 466 234 422 74 1.7k
J R Farndon 780 453 301 473 57 2.2k
H. Richard Alexander 565 328 169 474 61 1.8k
David Nathanson 889 213 397 491 73 2.0k
Elínborg J. Ólafsdóttir 827 355 262 257 45 1.8k
T.W.J. Lennard 464 270 258 348 70 1.5k
Gerry Thomas 517 153 254 868 49 1.6k
Katherine Liau 1082 833 436 382 36 2.0k
Shuanzeng Wei 486 1002 527 374 72 2.0k

All Works

Loading papers...

Rankless by CCL
2026